Tekla Capital Management LLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 308 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2020. The put-call ratio across all filers is 1.16 and the average weighting 0.3%.

Quarter-by-quarter ownership
Tekla Capital Management LLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q2 2023$1,650,697
-4.7%
105,0730.0%0.06%
-1.5%
Q1 2023$1,731,603
+5.6%
105,0730.0%0.07%
+6.5%
Q4 2022$1,639,139
+20.3%
105,0730.0%0.06%
+10.7%
Q3 2022$1,363,000
-7.6%
105,0730.0%0.06%
-3.4%
Q2 2022$1,475,000
-51.0%
105,073
-50.0%
0.06%
-45.3%
Q1 2022$3,009,000
+5.1%
210,1460.0%0.11%
+15.2%
Q4 2021$2,864,000
-16.8%
210,1460.0%0.09%
-17.1%
Q3 2021$3,442,000
-2.7%
210,1460.0%0.11%
-3.5%
Q2 2021$3,537,000
-7.8%
210,1460.0%0.12%
-12.9%
Q1 2021$3,837,000
+0.3%
210,1460.0%0.13%
-1.5%
Q4 2020$3,825,000
+2.0%
210,1460.0%0.13%
-4.3%
Q3 2020$3,749,000
-0.5%
210,1460.0%0.14%
-2.1%
Q2 2020$3,768,000
+18.1%
210,1460.0%0.14%
-0.7%
Q1 2020$3,190,000
-23.1%
210,1460.0%0.14%
-8.3%
Q4 2019$4,146,000
+14.7%
210,1460.0%0.16%
-0.6%
Q3 2019$3,615,000
+14.7%
210,146
+18.0%
0.16%
+22.5%
Q2 2019$3,153,000
-13.1%
178,1280.0%0.13%
-12.2%
Q1 2019$3,628,000178,1280.15%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q2 2020
NameSharesValueWeighting ↓
Glenview Capital Management 16,104,222$294,063,0004.98%
GMT CAPITAL CORP 2,468,695$45,078,0003.31%
MANAGED ASSET PORTFOLIOS, LLC 1,065,756$19,461,0003.13%
Blackcrane Capital, LLC 14,571$1,723,0002.72%
BFAM Partners (Cayman) Ltd 328,690$6,002,0002.36%
Paulson & Co. 4,727,415$86,323,0001.98%
Mondrian Investment Partners LTD 3,510,404$59,677,0001.28%
Lumbard & Kellner, LLC 135,550$2,264,0000.80%
DAVIDSON INVESTMENT ADVISORS 500,203$9,134,0000.78%
TFG Asset Management GP Ltd 589,390$10,762,0000.77%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders